| CA-19-9, Gastric & Pancreatic Cancer, ELISA Kit
|
| CA-19-9 Gastrointestinal Tumor Assoc Marker 19-9, Sialyl Lacto-N-fucopentose, Lewis A, Cl: B46,Mab anti-Hu,frozen/paraffin
|
| CA242 (GASTROINTESTINAL CANCER) |
| CagA(Standard Range: 0-240 RU/ml //sensit. vs Western Blot: 93.7 %)
|
| CAGCCATGGCTG, 5'-NON-PHOSPHORYLATED |
| CAGCCATGGCTG, 5'-PHOSPHORYLATED |
| CAEVM protocol |
| CYS-D-ALA-PHE-LEU-VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU |
| C3a [Fmoc-Glu70, Ala71,72, Lys74] (70-77) [Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg]
|
| 141911-75-3 | CAf1M protein |
| 154026-67-2 | 笼状 CA2+ 通道拮抗剂 |
| caged FEDA-ATP |
| caged sphingosine 1-phosphate |
| caged isocitrate |
| 125455-57-4 | 'CAGED GTP |
| CAGED GLUTAMIC ACID |
| CAGED GABA |
| CAGED ASPARTIC ACID, SODIUM SALT |
| CAGED CGMP |
| Caged Glutamic Acid, Sodium Salt |
| Caged GTP, Dimethoxy-, Trisodium Salt |
| Caged GABA, Sodium Salt |
| Caged Ins(1,4,5)P3, L pack
|
| Caged Ins(1,4,5)P3, S pack
|
| CAGED FLUORESCEIN
|
| CAGED FLUORESCEIN SULFO-OSU
|
| CAGED INS(1,4,5)P3, TRISODIUM SALT |
| 171800-68-3 | 腺苷5`-三磷酸Γ-[1-(2-硝基苯基)乙基]酯钠盐 |
| 207516-11-8 | CAGED D-ERYTHRO-SPHINGOSINE-1-PHOSPHATE |
| CAGED FLUORESCEIN MALEIMIDE |
| 36885-29-7 | 二(6,6,7,7,8,8,8-七氟-2,2-二甲基-3,5-辛二酮)钙 |
| 167776-24-1 | CAGED FLUORESCEIN MALEIMIDE* |
| caged AIP |
| CAGEDFULLERENEDERIVATIVE |
| caged cyclic ADP-ribose |
| caged nuclear localization signal |
| CA150, exon 1 (Transcription Factor CA150, TCERG1, Transcription Elongation Regulator 1, TAF2S, TATA Box-Binding Protein-Associated Factor 2S)
|
| CAGDOWN PRIMER |
| 石英毛细管柱架 |
| CAGDRLTGIPSHILNSSPSD |
| cager-2 protein |
| CAF-PH protocol |
| cager-1 protein |
| 5' CAG GAA ACA GCT ATG ACC 3' |
| CAGGCGCCTG, 5'-NON-PHOSPHORYLATED |
| CAGGCGCCTG, 5'-PHOSPHORYLATED |
| CAF-1 protein, Drosophila |
| caf1 protein, Yersinia pestis |
| CAF protocol 2 |
| CAF protocol |
| CA 19-9 (GI Cancer Marker Test)
|
| CAFRQVCHTTVPWPNASLTP |
| 67879-58-7 | 咖啡酰基酒石酸 |
| 咖啡酰基酒石酸 |
| Caftaric acid o-quinone |
| CAFVP protocol |
| CA549 glycoprotein |
| 51732-61-7 | 7C-aglycone |
| 34927-45-2 | 5C-aglycone |
| CA GLYCEROPHOSPHATE |
| 115774-57-7 | cagocel-1 |
| 147387-25-5 | CAG1 protein |
| CAG protocol |
| CAG7 protein |
| CAG Repeat Length Mutation in Huntington's Disease |
| 869376-90-9 | CB-52 |
| 1150586-64-3 | CB-86 |
| 1391054-76-4 | CB 80 |
| 289715-28-2 | 4-[[[7-氯-3,4-二氢-3-甲基-2-[(4-甲基-1-哌嗪基)甲基]-4-氧代-6-喹唑啉基]甲基]-2-丙炔-1-基氨基]-N-(3-吡啶基甲基)苯甲酰胺 |
| 165307-47-1 | CB184; CB 184 |
| 206275-15-2 | CB 30865 |
| CB 34 |
| 假单胞菌选择性肉汤 |
| 59454-35-2 | 4-癸基-4-氰基联苯 |
| CB101 |
| CB28 |
| CB 54 |
| 128312-71-0 | CB 966 |
| CB 182 |
| 32808-58-5 | CB 848 |
| 32780-41-9 | CB 844 |
| CB105 |
| 193979-75-8 | CB 34 |
| 869376-63-6 | CB-25 |
| 432047-72-8 | 1-萘基[4-(戊氧基)-1-萘基]甲酮 |
| CAGR1 protein |
| CaiA protein |
| CAGUP PRIMER |
| 24739-08-0 | C(14a)-Homo-27-nor-14beta-gammaceran-3alpha-ol |
| C(14A)-HOMO-27-NORGCERA-13,15,17-TRIENE-3B,15,21A-TRIOL3,21-DIACETATE |
| C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIACETOXYPHENYL)PROPIONATE) |
| C(14A)-HOMO-27-NOR-3B,14B,21A-GCERANETRIOL3,21-DIACETATE |
| C(14A)-HOMO-27-NORGCER-14-ENE-3B,21A-DIOL21-ACETATE3-(3-(3,4-DIMETHOXYPHENYL)PROPIONATE) |
| 18070-14-9 | C(14a)-Homo-27-nor-5α-gammacer-13-ene |
| 18188-24-4 | C(14a)-Homo-27-norgammacerane-3β,21α-diol |
| 25329-73-1 | (14β)-C(14a)-Homo-27-norgammacerane-3,21-dione |
| 28618-19-1 | C(14a)-Homo-27-norgammacerane-3β,14β,21α-triol |
| 1449-07-6 | C(14a)-Homo-27-norgammacera-14-ene-3,21-dione |
| 18046-86-1 | C(14a)-Homo-27-norgammacer-14-ene |
| 77311-65-0 | C(14a)-Homo-27-norgammacer-14-ene-3β,20β,21β,24-tetrol |